OTCMKTS:STXS - Stereotaxis Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.80 +0.05 (+6.67 %)
(As of 05/21/2018 03:23 AM ET)
Previous Close$0.80
Today's Range$0.73 - $0.80
52-Week Range$0.51 - $1.10
Volume29,108 shs
Average Volume36,976 shs
Market Capitalization$47.14 million
P/E RatioN/A
Dividend YieldN/A
Beta3.45

About Stereotaxis (OTCMKTS:STXS)

Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Receive STXS News and Ratings via Email

Sign-up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:STXS
CUSIPN/A
Phone314-678-6100

Debt

Debt-to-Equity RatioN/A
Current Ratio1.72
Quick Ratio0.29

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$31.14 million
Price / Sales1.51
Cash Flow$0.0865 per share
Price / Cash9.25
Book Value$0.04 per share
Price / Book20.00

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-5,880,000.00
Net Margins-18.08%
Return on Equity-8.52%
Return on Assets9.14%

Miscellaneous

Employees117
Outstanding Shares58,930,000

Stereotaxis (OTCMKTS:STXS) Frequently Asked Questions

What is Stereotaxis' stock symbol?

Stereotaxis trades on the OTCMKTS under the ticker symbol "STXS."

How were Stereotaxis' earnings last quarter?

Stereotaxis (OTCMKTS:STXS) posted its quarterly earnings data on Monday, May, 14th. The medical equipment provider reported $0.01 EPS for the quarter. The medical equipment provider had revenue of $6.97 million for the quarter. Stereotaxis had a negative return on equity of 8.52% and a negative net margin of 18.08%. View Stereotaxis' Earnings History.

When is Stereotaxis' next earnings date?

Stereotaxis is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for Stereotaxis.

Who are some of Stereotaxis' key competitors?

Who are Stereotaxis' key executives?

Stereotaxis' management team includes the folowing people:
  • Mr. David Leo Fischel CFA, CPA, Chairman & CEO (Age 31)
  • Mr. Martin C. Stammer, Chief Financial Officer (Age 38)
  • Ms. Karen Witte Duros, Sr. VP, Gen. Counsel, Compliance Officer and Sec. (Age 63)
  • Dr. Gery Tomassoni M.D., FHRS, Chief Medical Officer
  • Dr. J. David Burkhardt M.D., F.A.C.C., Chief Devel. Advisor

Has Stereotaxis been receiving favorable news coverage?

News stories about STXS stock have been trending somewhat positive on Monday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Stereotaxis earned a daily sentiment score of 0.18 on Accern's scale. They also gave news headlines about the medical equipment provider an impact score of 47.53 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are Stereotaxis' major shareholders?

Stereotaxis' stock is owned by many different of institutional and retail investors. Top institutional shareholders include DAFNA CAPITAL MANAGEMENT LLC (23.40%) and KIANI JOE E (10.60%). View Institutional Ownership Trends for Stereotaxis.

How do I buy shares of Stereotaxis?

Shares of STXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Stereotaxis' stock price today?

One share of STXS stock can currently be purchased for approximately $0.80.

How big of a company is Stereotaxis?

Stereotaxis has a market capitalization of $47.14 million and generates $31.14 million in revenue each year. Stereotaxis employs 117 workers across the globe.

How can I contact Stereotaxis?

Stereotaxis' mailing address is 4320 FOREST PARK AVENUE, ST.LOUIS MO, 63108. The medical equipment provider can be reached via phone at 314-678-6100 or via email at [email protected]


MarketBeat Community Rating for Stereotaxis (STXS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  63 (Vote Underperform)
Total Votes:  112
MarketBeat's community ratings are surveys of what our community members think about Stereotaxis and other stocks. Vote "Outperform" if you believe STXS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STXS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Stereotaxis (OTCMKTS:STXS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/21/2016 forward)

Earnings

Stereotaxis (OTCMKTS:STXS) Earnings History and Estimates Chart

Earnings by Quarter for Stereotaxis (OTCMKTS:STXS)

Stereotaxis (OTCMKTS STXS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2018        
5/14/2018Q1 2018$0.01$6.97 millionViewN/AView Earnings Details
3/6/2018Q4 2017($0.01)$7.56 millionViewListenView Earnings Details
11/9/2017Q3 2017($0.02)$8.14 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.02)$8.47 millionViewN/AView Earnings Details
5/8/2017Q1 2017$0.01$6.98 millionViewListenView Earnings Details
3/16/2017Q4 2016$0.24$7.31 millionViewN/AView Earnings Details
11/7/2016Q3 2016($0.09)$8.33 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.11)$7.88 millionViewN/AView Earnings Details
5/9/2016Q1($0.11)$9.50 million$8.60 millionViewListenView Earnings Details
2/22/2016Q4($0.10)$9.80 million$9.20 millionViewListenView Earnings Details
11/3/2015Q3($0.05)$8.90 million$9.30 millionViewListenView Earnings Details
8/4/2015Q215($0.12)$120.60 million$9.66 millionViewN/AView Earnings Details
5/6/2015Q115($0.15)$8.40 million$9.50 millionViewListenView Earnings Details
2/25/2015Q414$0.04$9.10 million$9.80 millionViewListenView Earnings Details
11/5/2014Q3 2014($0.10)$8.85 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.16)$8.05 millionViewN/AView Earnings Details
5/6/2014Q1($0.16)$8.40 million$8.40 millionViewListenView Earnings Details
2/25/2014Q4($0.19)$12.20 million$9.10 millionViewListenView Earnings Details
11/12/2013Q3($0.26)$9.70 million$10.80 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.59)($0.37)$10.80 million$9.70 millionViewListenView Earnings Details
5/13/2013Q1 2013($0.50)($0.61)$12.00 million$8.40 millionViewListenView Earnings Details
3/5/2013Q4 2012($0.40)($0.29)ViewN/AView Earnings Details
11/5/2012Q312($0.72)($0.33)$10.30 million$11.60 millionViewN/AView Earnings Details
8/6/2012Q2 2012($0.86)($0.91)ViewN/AView Earnings Details
5/8/2012Q1 2012($1.10)($1.06)ViewN/AView Earnings Details
3/5/2012($0.14)($0.10)ViewN/AView Earnings Details
11/7/2011($0.16)($0.13)ViewN/AView Earnings Details
8/8/2011($0.12)($0.18)ViewN/AView Earnings Details
5/2/2011($0.13)($0.17)ViewN/AView Earnings Details
2/28/2011($0.11)($0.05)ViewN/AView Earnings Details
11/1/2010Q3 2010($0.80)($1.03)ViewN/AView Earnings Details
8/2/2010Q2 2010($1.30)($0.77)ViewN/AView Earnings Details
5/6/2010Q1 2010($1.60)($1.70)ViewN/AView Earnings Details
2/25/2010Q4 2009($1.30)($1.39)ViewN/AView Earnings Details
11/5/2009Q3 2009($1.80)($1.38)ViewN/AView Earnings Details
8/6/2009Q2 2009($2.10)($1.79)ViewN/AView Earnings Details
5/7/2009Q1 2009($2.20)($1.82)ViewN/AView Earnings Details
2/26/2009Q4 2008($2.40)($2.04)ViewN/AView Earnings Details
11/6/2008Q3 2008($2.70)($2.75)ViewN/AView Earnings Details
8/5/2008Q2 2008($3.30)($3.50)ViewN/AView Earnings Details
5/6/2008Q1 2008($3.30)($3.71)ViewN/AView Earnings Details
3/3/2008Q4 2007($2.90)($3.36)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Stereotaxis (OTCMKTS:STXS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Stereotaxis (OTCMKTS STXS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 38.09%
Institutional Ownership Percentage: 2.35%
Insider Trading History for Stereotaxis (OTCMKTS:STXS)

Stereotaxis (OTCMKTS STXS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2015Fred A MiddletonDirectorSell26,064$1.57$40,920.48View SEC Filing  
6/12/2015Fred A MiddletonDirectorSell16,273$1.61$26,199.53View SEC Filing  
6/9/2015Fred A MiddletonDirectorSell106,876$1.65$176,345.40View SEC Filing  
3/13/2015David BenferDirectorBuy3,000$1.95$5,850.00View SEC Filing  
12/12/2014William C Mills IIICEOBuy10,000$1.45$14,500.00View SEC Filing  
12/9/2014Fred A MiddletonDirectorSell8,551$1.51$12,912.01View SEC Filing  
12/5/2014William C Mills IIICEOBuy10,000$1.43$14,300.00View SEC Filing  
12/3/2014Fred A MiddletonDirectorSell15,809$1.59$25,136.31View SEC Filing  
8/11/2014William C Mills IIICEOBuy10,000$2.75$27,500.00View SEC Filing  
3/13/2014Fred A MiddletonDirectorSell24,302$4.21$102,311.42View SEC Filing  
8/23/2013Fred A MiddletonDirectorSell14,600$3.67$53,582.00View SEC Filing  
8/20/2013Christopher D AlafiMajor ShareholderSell261,241$3.74$977,041.34View SEC Filing  
8/7/2013Fred A MiddletonDirectorSell78,974$10.13$800,006.62View SEC Filing  
11/30/2012Fred A MiddletonDirectorBuy24,360$1.53$37,270.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Stereotaxis (OTCMKTS STXS) News Headlines

Source:
DateHeadline
Edited Transcript of STXS earnings conference call or presentation 14-May-18 2:00pm GMTEdited Transcript of STXS earnings conference call or presentation 14-May-18 2:00pm GMT
finance.yahoo.com - May 15 at 10:00 AM
Stereotaxis (STXS) CEO David Fischel on Q1 2018 Results - Earnings Call TranscriptStereotaxis' (STXS) CEO David Fischel on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 4:28 PM
Stereotaxis (STXS) Announces Quarterly  Earnings ResultsStereotaxis (STXS) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 14 at 12:54 PM
Stereotaxis, Inc. to Host Earnings CallStereotaxis, Inc. to Host Earnings Call
finance.yahoo.com - May 14 at 10:20 AM
Stereotaxis Reports 2018 First Quarter Financial ResultsStereotaxis Reports 2018 First Quarter Financial Results
finance.yahoo.com - May 14 at 10:20 AM
Stereotaxis (STXS) Scheduled to Post Earnings on MondayStereotaxis (STXS) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - May 7 at 8:28 AM
Stereotaxis to Report First Quarter 2018 Financial Results on May 14, 2018Stereotaxis to Report First Quarter 2018 Financial Results on May 14, 2018
finance.yahoo.com - May 4 at 9:24 AM
Stereotaxis to Highlight Unique Advantages of Robotic Cardiac Ablation at Heart Rhythm 2018Stereotaxis to Highlight Unique Advantages of Robotic Cardiac Ablation at Heart Rhythm 2018
finance.yahoo.com - May 4 at 9:24 AM
Stereotaxis and Acutus Medical Announce Strategic CollaborationStereotaxis and Acutus Medical Announce Strategic Collaboration
finance.yahoo.com - May 3 at 4:24 PM
Stereotaxis Announces Expanded European Labeling for Navigation in the Pericardial SpaceStereotaxis Announces Expanded European Labeling for Navigation in the Pericardial Space
finance.yahoo.com - April 11 at 10:09 AM
Edited Transcript of STXS earnings conference call or presentation 6-Mar-18 3:00pm GMTEdited Transcript of STXS earnings conference call or presentation 6-Mar-18 3:00pm GMT
finance.yahoo.com - March 18 at 9:25 AM
Stereotaxis (STXS) Issues Quarterly  Earnings ResultsStereotaxis (STXS) Issues Quarterly Earnings Results
www.americanbankingnews.com - March 6 at 12:03 PM
The Story Behind Growth: New Report Discusses Stereotaxis and OurPets Co. - Emerging Trends Within New IndustryThe Story Behind Growth: New Report Discusses Stereotaxis and OurPet's Co. - Emerging Trends Within New Industry
finance.yahoo.com - March 6 at 9:20 AM
Stereotaxis Announces $10.0 Million Non-Dilutive Financing from Early Warrant ExerciseStereotaxis Announces $10.0 Million Non-Dilutive Financing from Early Warrant Exercise
finance.yahoo.com - March 6 at 9:20 AM
Stereotaxis Reports 2017 Fourth Quarter and Full Year Financial ResultsStereotaxis Reports 2017 Fourth Quarter and Full Year Financial Results
finance.yahoo.com - March 6 at 9:20 AM
Stereotaxis (STXS) Scheduled to Post Earnings on TuesdayStereotaxis (STXS) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - March 5 at 6:10 PM
Stereotaxis to Report Fourth Quarter and Full Year 2017 Financial Results on March 6, 2018Stereotaxis to Report Fourth Quarter and Full Year 2017 Financial Results on March 6, 2018
finance.yahoo.com - March 2 at 9:23 AM
European Heart Rhythm Association Highlights Occupational Risk of Radiation Exposure in Electrophysiology ProceduresEuropean Heart Rhythm Association Highlights Occupational Risk of Radiation Exposure in Electrophysiology Procedures
finance.yahoo.com - February 1 at 9:12 AM
Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue ResultsStereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results
finance.yahoo.com - January 8 at 10:26 AM
Stereotaxis Receives Regulatory Approval of e-Contact™ Module in CanadaStereotaxis Receives Regulatory Approval of e-Contact™ Module in Canada
finance.yahoo.com - December 5 at 3:15 PM
Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 8:27 AM
Stereotaxis to Present at 29th Annual Piper Jaffray Healthcare ConferenceStereotaxis to Present at 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 20 at 10:36 AM
Edited Transcript of STXS earnings conference call or presentation 9-Nov-17 3:00pm GMTEdited Transcript of STXS earnings conference call or presentation 9-Nov-17 3:00pm GMT
finance.yahoo.com - November 10 at 10:58 AM
Stereotaxis (STXS) CEO David Fischel on Q3 2017 Results - Earnings Call TranscriptStereotaxis' (STXS) CEO David Fischel on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 9 at 2:09 PM
Stereotaxis Reports Third Quarter 2017 Financial ResultsStereotaxis Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 9 at 2:09 PM

SEC Filings

Stereotaxis (OTCMKTS:STXS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Stereotaxis (OTCMKTS:STXS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Stereotaxis (OTCMKTS STXS) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.